The effect of sympathetic blockade time by stellate ganglion block on the treatment effect of trigeminal neuropathy

The effect of sympathetic blockade time by stellate ganglion block on the treatment effect of trigeminal neuropathy - Effect of sympathetic blockade time on trigeminal neuropathy

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000042817

Enrollment

Registered

2020-12-22

Start date

2018-12-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Trigeminal Neuropathy

Interventions

Stellate ganglion block with levobupivacaine Stellate ganglion block with mepivacaine

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients of both sexes, aged 20 years or older, who were undergoing Le Fort I osteotomy of the maxilla or bilateral sagittal split ramus osteotomy (BSSRO) at Kyushu Dental University Hospital, with an American Society of Anesthesiologists physical status I or II, and who had a diagnosis of infraorbital nerve (ION) and inferior alveolar nerve (IAN) sensory disturbances were included.

Exclusion criteria

Exclusion criteria: The exclusion criteria were an allergy to the drugs used in this study, pre-existing orofacial sensory impairment, a history of facial trauma or surgery, and major psychiatric disorders.

Design outcomes

Primary

Measure	Time frame
Quantitative sensory testing	—

Countries

Japan

Contacts

Public ContactShunji Shiiba

Kyushu Dental University Department of Science of Physical Functions, Division of Dental Anesthesiology

shiiba@fa.kyu-dent.ac.jp093-582-1131

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026